These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17718241)

  • 1. [The pathology of ocular syndromes caused by toxicity].
    Lasudry J
    Bull Soc Belge Ophtalmol; 2007; (304):155-78. PubMed ID: 17718241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular side effects of drugs].
    Müller-Breitenkamp U; Hockwin O
    Laryngorhinootologie; 1992 Apr; 71(4):226-8. PubMed ID: 1575856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness.
    Situ P; Simpson TL; Fonn D; Jones LW
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Vera LS; Gueudry J; Delcampe A; Roujeau JC; Brasseur G; Muraine M
    Cornea; 2009 May; 28(4):401-7. PubMed ID: 19411958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of ocular surface disease in glaucoma patients.
    Leung EW; Medeiros FA; Weinreb RN
    J Glaucoma; 2008 Aug; 17(5):350-5. PubMed ID: 18703943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult thyroid eye disease in patients presenting with dry eye symptoms.
    Gupta A; Sadeghi PB; Akpek EK
    Am J Ophthalmol; 2009 May; 147(5):919-23. PubMed ID: 19211095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine-induced Stevens-Johnson syndrome in an HIV patient.
    Jain V; Shome D; Natarajan S
    Cornea; 2008 Apr; 27(3):366-7. PubMed ID: 18362670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin.
    Karalezli A; Borazan M; Altinors DD; Dursun R; Kiyici H; Akova YA
    Cornea; 2009 Jan; 28(1):46-50. PubMed ID: 19092405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blinking and tear break-up during four visual tasks.
    Himebaugh NL; Begley CG; Bradley A; Wilkinson JA
    Optom Vis Sci; 2009 Feb; 86(2):E106-14. PubMed ID: 19156014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset.
    Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S
    Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of floppy eyelid syndrome in ocular surface and dry eye disease.
    Mastrota KM
    Optom Vis Sci; 2008 Sep; 85(9):814-6. PubMed ID: 18772717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear film with "Orgahexa EyeMasks" in patients with meibomian gland dysfunction.
    Ishida R; Matsumoto Y; Onguchi T; Kaido M; Iwamuro K; Kobayashi J; Takano Y; Shimazaki J; Goto E; Dogru M; Tsubota K
    Optom Vis Sci; 2008 Aug; 85(8):684-91. PubMed ID: 18677224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
    Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
    Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular dryness related to systemic medications].
    Creuzot-Garcher C
    J Fr Ophtalmol; 2009 Jan; 32(1):64-70. PubMed ID: 19515318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.